Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Hematological manifestations of SARS-CoV-2 in children.

Tytuł:
Hematological manifestations of SARS-CoV-2 in children.
Autorzy:
Kosmeri C; Department of Pediatrics, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Koumpis E; Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Tsabouri S; Department of Pediatrics, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Siomou E; Department of Pediatrics, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Makis A; Department of Pediatrics, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Dec; Vol. 67 (12), pp. e28745. Date of Electronic Publication: 2020 Oct 03.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Original Publication: Hoboken, N.J. : John Wiley, c 2004-
MeSH Terms:
Pandemics*
Anemia/*blood
Betacoronavirus/*metabolism
Coronavirus Infections/*blood
Lymphopenia/*blood
Pneumonia, Viral/*blood
Thrombophilia/*blood
Adolescent ; Anemia/epidemiology ; Anemia/immunology ; Betacoronavirus/immunology ; Biomarkers/blood ; Blood Platelets/immunology ; Blood Platelets/metabolism ; COVID-19 ; Child ; Child, Preschool ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Erythrocytes/immunology ; Erythrocytes/metabolism ; Female ; Humans ; Infant ; Infant, Newborn ; Leukocyte Count ; Lymphopenia/epidemiology ; Lymphopenia/immunology ; Male ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; SARS-CoV-2 ; Thrombophilia/epidemiology ; Thrombophilia/immunology
References:
Curr Med Sci. 2020 Apr;40(2):275-280. (PMID: 32207032)
J Pediatr. 2020 Aug;223:14-19.e2. (PMID: 32407719)
Lancet Infect Dis. 2020 Jun;20(6):689-696. (PMID: 32220650)
J Thromb Thrombolysis. 2020 Jul;50(1):54-67. (PMID: 32415579)
Lancet. 2020 Jun 6;395(10239):1771-1778. (PMID: 32410760)
Pediatr Blood Cancer. 2020 Dec;67(12):e28505. (PMID: 32588954)
Children (Basel). 2020 Jul 01;7(7):. (PMID: 32630212)
JAMA. 2020 Apr 7;323(13):1239-1242. (PMID: 32091533)
Pediatr Blood Cancer. 2020 Sep;67(9):e28382. (PMID: 32495391)
JAMA. 2020 Jul 21;324(3):259-269. (PMID: 32511692)
Pediatr Blood Cancer. 2020 Sep;67(9):e28432. (PMID: 32779861)
N Engl J Med. 2020 Jul 23;383(4):334-346. (PMID: 32598831)
Pediatr Blood Cancer. 2021 Feb;68(2):e28610. (PMID: 32779840)
Transfus Apher Sci. 2020 Oct;59(5):102866. (PMID: 32636116)
Clin Chem Lab Med. 2020 Jun 25;58(7):1135-1138. (PMID: 32172227)
Lancet Child Adolesc Health. 2020 Sep;4(9):669-677. (PMID: 32653054)
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6388-93. (PMID: 17405864)
Biochem J. 2005 Feb 1;385(Pt 3):831-8. (PMID: 15654766)
Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134. (PMID: 32119647)
Acta Paediatr. 2020 Jun;109(6):1088-1095. (PMID: 32202343)
Pediatr Blood Cancer. 2020 Sep;67(9):e28420. (PMID: 32588957)
Lancet. 2020 May 2;395(10234):1417-1418. (PMID: 32325026)
Pediatr Pulmonol. 2020 Sep;55(9):2419-2426. (PMID: 32579293)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Pediatr Blood Cancer. 2020 Jul;67(7):e28397. (PMID: 32383819)
BMJ. 2020 Jun 3;369:m2094. (PMID: 32493739)
N Engl J Med. 2020 Apr 2;382(14):1370-1371. (PMID: 32163697)
Int J Legal Med. 2020 Jul;134(4):1275-1284. (PMID: 32500199)
PLoS One. 2014 May 16;9(5):e98020. (PMID: 24837009)
Pediatr Infect Dis J. 2019 Mar;38(3):e54-e56. (PMID: 30461573)
J Infect Dis. 2015 Jan 1;211(1):80-90. (PMID: 25030060)
J Thromb Haemost. 2020 Apr;18(4):844-847. (PMID: 32073213)
Lancet. 2020 May 23;395(10237):1607-1608. (PMID: 32386565)
N Engl J Med. 2020 Jul 9;383(2):187-190. (PMID: 32356945)
Am J Hematol. 2020 Jul;95(7):834-847. (PMID: 32282949)
J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e859-e860. (PMID: 32852398)
Ann Intern Med. 2006 Oct 17;145(8):599-609. (PMID: 16940336)
N Engl J Med. 2020 Apr 23;382(17):1663-1665. (PMID: 32187458)
Nat Rev Rheumatol. 2016 May;12(5):259-68. (PMID: 27009539)
World J Pediatr. 2020 Jun;16(3):251-259. (PMID: 32193831)
Hemasphere. 2020 May 21;4(3):e409. (PMID: 32647807)
Ann Transl Med. 2020 May;8(10):623. (PMID: 32566560)
Acta Paediatr. 2020 Oct;109(10):1948-1955. (PMID: 32557789)
Pediatr Pulmonol. 2020 May;55(5):1169-1174. (PMID: 32134205)
Pediatr Res. 2021 Mar;89(4):733-737. (PMID: 32555539)
Blood. 2019 May 16;133(20):2186-2197. (PMID: 30898858)
J Med Virol. 2019 Jul;91(7):1191-1201. (PMID: 30763464)
Acta Paediatr. 2020 Nov;109(11):2311-2312. (PMID: 32640088)
Pediatr Rheumatol Online J. 2019 Feb 14;17(1):7. (PMID: 30764840)
Pediatr Blood Cancer. 2020 Nov;67(11):e28693. (PMID: 32885904)
Lancet Oncol. 2020 Mar;21(3):335-337. (PMID: 32066541)
JAMA. 2020 May 12;323(18):1775-1776. (PMID: 32203977)
Pediatr Pulmonol. 2020 Aug;55(8):2115-2127. (PMID: 32519809)
Pediatr Blood Cancer. 2020 Dec;67(12):e28745. (PMID: 33009893)
Pediatr Pulmonol. 2020 Oct;55(10):2556-2564. (PMID: 32710693)
Stem Cell Rev Rep. 2021 Feb;17(1):4-8. (PMID: 32399806)
Pediatr Blood Cancer. 2020 Sep;67(9):e28485. (PMID: 32558124)
Am J Otolaryngol. 2020 Sep - Oct;41(5):102573. (PMID: 32531620)
J Korean Med Sci. 2020 Jun 29;35(25):e236. (PMID: 32597047)
Thromb Res. 2020 Jul;191:145-147. (PMID: 32291094)
N Engl J Med. 2020 Jul 23;383(4):347-358. (PMID: 32598830)
J Immunol. 2002 Oct 15;169(8):4288-97. (PMID: 12370360)
JCI Insight. 2020 Jun 4;5(11):. (PMID: 32329756)
JAMA. 2020 Aug 4;324(5):460-470. (PMID: 32492084)
Nat Med. 2020 Jul;26(7):1017-1032. (PMID: 32651579)
JAMA Pediatr. 2020 Sep 01;174(9):868-873. (PMID: 32392288)
J Biol Regul Homeost Agents. 2020 Jun 1;34(3):767-773. (PMID: 32476380)
Pediatr Crit Care Med. 2020 Oct;21(10):e948-e953. (PMID: 32639466)
J Med Virol. 2021 Jan;93(1):234-240. (PMID: 32558955)
N Engl J Med. 2020 Apr 23;382(17):e38. (PMID: 32268022)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
Indian Pediatr. 2020 Sep 15;57(9):820-826. (PMID: 32583808)
JAMA. 2020 Jul 21;324(3):294-296. (PMID: 32511676)
J Clin Invest. 2020 Nov 2;130(11):5942-5950. (PMID: 32701511)
Bone Marrow Transplant. 2020 Oct;55(10):1900-1905. (PMID: 32313181)
Int J Oral Sci. 2020 Feb 24;12(1):8. (PMID: 32094336)
Lancet Respir Med. 2020 May;8(5):475-481. (PMID: 32105632)
J Pediatr. 2020 Sep;224:141-145. (PMID: 32553873)
Thromb Res. 2020 Oct;194:36-41. (PMID: 32569879)
Circulation. 2020 Aug 4;142(5):429-436. (PMID: 32418446)
Vasc Med. 2020 Oct;25(5):471-478. (PMID: 32558620)
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5. (PMID: 20798043)
Clin Infect Dis. 2021 May 4;72(9):e397-e401. (PMID: 32710613)
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765. (PMID: 32555134)
JAMA Pediatr. 2020 Sep 01;174(9):882-889. (PMID: 32320004)
Clin Exp Med. 2020 Nov;20(4):493-506. (PMID: 32720223)
Contributed Indexing:
Keywords: COVID-19; MIS; SARS-CoV-2; children; hematological manifestations
Substance Nomenclature:
0 (Biomarkers)
Entry Date(s):
Date Created: 20201003 Date Completed: 20201102 Latest Revision: 20231112
Update Code:
20240105
PubMed Central ID:
PMC7646039
DOI:
10.1002/pbc.28745
PMID:
33009893
Czasopismo naukowe
Infection from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), though mainly a respiratory disease, can impair many systems, including causing hematological complications. Lymphopenia and hypercoagulability have been reported in adults with coronavirus disease 2019 (COVID-19) and are considered markers of poor prognosis. This review summarizes the hematological findings in children with SARS-CoV-2 infection. The majority of infected children had a normal leukocyte count, while the most common white blood cell abnormality was leukopenia. Lymphopenia, which may be a marker of severe disease, was rarer in children than in adults, possibly due to their immature immune system or due to the less severe manifestation of COVID-19 in this age group. Age may have an impact, and in neonates and infants the most common abnormality was lymphocytosis. Abnormalities of red blood cells and platelets were uncommon. Anemia and hypercoagulability were reported mainly in children presenting the novel multisystem inflammatory syndrome (MIS) associated with SARS-CoV-2.
(© 2020 Wiley Periodicals LLC.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies